课题基金 / 基金详情

Inhibition of CBP/p300 bromodomain activity increases chemosensitivity of p53 mutant colorectal cancers through inhibiting p53 aggregation

Inhibition of CBP/p300 bromodomain activity increases chemosensitivity of p53 mutant colorectal cancers through inhibiting p53 aggregation
抑制 CBP/p300 溴结构域活性通过抑制 p53 聚集增加 p53 突变结直肠癌的化疗敏感性
批准号:
472399
负责人:
O'Brien Catherine A
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-09-01 至 2023-09-01

项目摘要

项目成果

O'Brien Catherine A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
p53 mutations are found in over 50% of cancers and are often associated with a worse outcome for patients. It is well established that chemotherapy can cause mutant p53 to form aggregates, hereafter refered to as protein "clumps". We uncovered a previousl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular drivers of the drug tolerant persister state in patient-derived colorectal cancer models
  • 批准号:
    434963
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.94万
  • 财政年份:
    2020
  • 负责人:
    O'Brien Catherine A
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    415401
  • 项目类别:
  • 资助金额:
    $43.71万
  • 财政年份:
    2019
  • 负责人:
    O'Brien Catherine A
  • 依托单位:
Colorectal cancer stem cell plasticity: A novel therapeutic target
  • 批准号:
    334266
  • 项目类别:
    Operating Grants
  • 资助金额:
    $88.93万
  • 财政年份:
    2015
  • 负责人:
    O'Brien Catherine A
  • 依托单位:
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.
  • 批准号:
    302201
  • 项目类别:
    Salary Programs
  • 资助金额:
    $21.86万
  • 财政年份:
    2013
  • 负责人:
    O'Brien Catherine A
  • 依托单位:
海外基金